Day Range0.068 - 0.072 | 52 Wk Range0.059 - 4.540 | Open / Close0.070 / 0.070 | Float / Outstanding43.638M / 43.683M |
Vol / Avg.8.881M / 9.799M | Mkt Cap3.040M | P/E- | 50d Avg. Price0.110 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float43.638M | EPS-1.520 |
ContraFect Stock (NASDAQ: CFRX) stock price, news, charts, stock research, profile.
Day Range0.068 - 0.072 | 52 Wk Range0.059 - 4.540 | Open / Close0.070 / 0.070 | Float / Outstanding43.638M / 43.683M |
Vol / Avg.8.881M / 9.799M | Mkt Cap3.040M | P/E- | 50d Avg. Price0.110 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float43.638M | EPS-1.520 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-23 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.230 | -0.430 | -0.2000 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of ContraFect (NASDAQ: CFRX) through any online brokerage.
Other companies in ContraFect’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Bone Biologics (NASDAQ:BBLG), Histogen (NASDAQ:HSTO), Midatech Pharma (NASDAQ:MTP) and OncoSec Medical (NASDAQ:ONCS).
The latest price target for ContraFect (NASDAQ: CFRX) was reported by Maxim Group on Thursday, July 14, 2022. The analyst firm set a price target for 0.00 expecting CFRX to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
The stock price for ContraFect (NASDAQ: CFRX) is $0.0696 last updated February 3, 2023 at 9:00 PM UTC.
There are no upcoming dividends for ContraFect.
ContraFect’s Q4 earnings are confirmed for Thursday, March 23, 2023.
There is no upcoming split for ContraFect.
ContraFect is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
ContraFect Stock (NASDAQ: CFRX) stock price, news, charts, stock research, profile.
Day Range0.068 - 0.072 | 52 Wk Range0.059 - 4.540 | Open / Close0.070 / 0.070 | Float / Outstanding43.638M / 43.683M |
Vol / Avg.8.881M / 9.799M | Mkt Cap3.040M | P/E- | 50d Avg. Price0.110 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float43.638M | EPS-1.520 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-23 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.230 | -0.430 | -0.2000 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of ContraFect (NASDAQ: CFRX) through any online brokerage.
Other companies in ContraFect’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Bone Biologics (NASDAQ:BBLG), Histogen (NASDAQ:HSTO), Midatech Pharma (NASDAQ:MTP) and OncoSec Medical (NASDAQ:ONCS).
The latest price target for ContraFect (NASDAQ: CFRX) was reported by Maxim Group on Thursday, July 14, 2022. The analyst firm set a price target for 0.00 expecting CFRX to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
The stock price for ContraFect (NASDAQ: CFRX) is $0.0696 last updated February 3, 2023 at 9:00 PM UTC.
There are no upcoming dividends for ContraFect.
ContraFect’s Q4 earnings are confirmed for Thursday, March 23, 2023.
There is no upcoming split for ContraFect.
ContraFect is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
ContraFect Stock (NASDAQ: CFRX) stock price, news, charts, stock research, profile.
Day Range0.068 - 0.072 | 52 Wk Range0.059 - 4.540 | Open / Close0.070 / 0.070 | Float / Outstanding43.638M / 43.683M |
Vol / Avg.8.881M / 9.799M | Mkt Cap3.040M | P/E- | 50d Avg. Price0.110 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float43.638M | EPS-1.520 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-23 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.230 | -0.430 | -0.2000 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of ContraFect (NASDAQ: CFRX) through any online brokerage.
Other companies in ContraFect’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Bone Biologics (NASDAQ:BBLG), Histogen (NASDAQ:HSTO), Midatech Pharma (NASDAQ:MTP) and OncoSec Medical (NASDAQ:ONCS).
The latest price target for ContraFect (NASDAQ: CFRX) was reported by Maxim Group on Thursday, July 14, 2022. The analyst firm set a price target for 0.00 expecting CFRX to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
The stock price for ContraFect (NASDAQ: CFRX) is $0.0696 last updated February 3, 2023 at 9:00 PM UTC.
There are no upcoming dividends for ContraFect.
ContraFect’s Q4 earnings are confirmed for Thursday, March 23, 2023.
There is no upcoming split for ContraFect.
ContraFect is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
ContraFect Stock (NASDAQ: CFRX) stock price, news, charts, stock research, profile.
Day Range0.068 - 0.072 | 52 Wk Range0.059 - 4.540 | Open / Close0.070 / 0.070 | Float / Outstanding43.638M / 43.683M |
Vol / Avg.8.881M / 9.799M | Mkt Cap3.040M | P/E- | 50d Avg. Price0.110 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float43.638M | EPS-1.520 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-23 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.230 | -0.430 | -0.2000 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of ContraFect (NASDAQ: CFRX) through any online brokerage.
Other companies in ContraFect’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Bone Biologics (NASDAQ:BBLG), Histogen (NASDAQ:HSTO), Midatech Pharma (NASDAQ:MTP) and OncoSec Medical (NASDAQ:ONCS).
The latest price target for ContraFect (NASDAQ: CFRX) was reported by Maxim Group on Thursday, July 14, 2022. The analyst firm set a price target for 0.00 expecting CFRX to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
The stock price for ContraFect (NASDAQ: CFRX) is $0.0696 last updated February 3, 2023 at 9:00 PM UTC.
There are no upcoming dividends for ContraFect.
ContraFect’s Q4 earnings are confirmed for Thursday, March 23, 2023.
There is no upcoming split for ContraFect.
ContraFect is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
ContraFect Stock (NASDAQ: CFRX) stock price, news, charts, stock research, profile.
Day Range0.068 - 0.072 | 52 Wk Range0.059 - 4.540 | Open / Close0.070 / 0.070 | Float / Outstanding43.638M / 43.683M |
Vol / Avg.8.881M / 9.799M | Mkt Cap3.040M | P/E- | 50d Avg. Price0.110 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float43.638M | EPS-1.520 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-23 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.230 | -0.430 | -0.2000 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of ContraFect (NASDAQ: CFRX) through any online brokerage.
Other companies in ContraFect’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Bone Biologics (NASDAQ:BBLG), Histogen (NASDAQ:HSTO), Midatech Pharma (NASDAQ:MTP) and OncoSec Medical (NASDAQ:ONCS).
The latest price target for ContraFect (NASDAQ: CFRX) was reported by Maxim Group on Thursday, July 14, 2022. The analyst firm set a price target for 0.00 expecting CFRX to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
The stock price for ContraFect (NASDAQ: CFRX) is $0.0696 last updated February 3, 2023 at 9:00 PM UTC.
There are no upcoming dividends for ContraFect.
ContraFect’s Q4 earnings are confirmed for Thursday, March 23, 2023.
There is no upcoming split for ContraFect.
ContraFect is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
ContraFect Stock (NASDAQ: CFRX) stock price, news, charts, stock research, profile.
Day Range0.068 - 0.072 | 52 Wk Range0.059 - 4.540 | Open / Close0.070 / 0.070 | Float / Outstanding43.638M / 43.683M |
Vol / Avg.8.881M / 9.799M | Mkt Cap3.040M | P/E- | 50d Avg. Price0.110 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float43.638M | EPS-1.520 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-23 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.230 | -0.430 | -0.2000 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of ContraFect (NASDAQ: CFRX) through any online brokerage.
Other companies in ContraFect’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Bone Biologics (NASDAQ:BBLG), Histogen (NASDAQ:HSTO), Midatech Pharma (NASDAQ:MTP) and OncoSec Medical (NASDAQ:ONCS).
The latest price target for ContraFect (NASDAQ: CFRX) was reported by Maxim Group on Thursday, July 14, 2022. The analyst firm set a price target for 0.00 expecting CFRX to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
The stock price for ContraFect (NASDAQ: CFRX) is $0.0696 last updated February 3, 2023 at 9:00 PM UTC.
There are no upcoming dividends for ContraFect.
ContraFect’s Q4 earnings are confirmed for Thursday, March 23, 2023.
There is no upcoming split for ContraFect.
ContraFect is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
ContraFect Stock (NASDAQ: CFRX) stock price, news, charts, stock research, profile.
Day Range0.068 - 0.072 | 52 Wk Range0.059 - 4.540 | Open / Close0.070 / 0.070 | Float / Outstanding43.638M / 43.683M |
Vol / Avg.8.881M / 9.799M | Mkt Cap3.040M | P/E- | 50d Avg. Price0.110 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float43.638M | EPS-1.520 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-23 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.230 | -0.430 | -0.2000 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of ContraFect (NASDAQ: CFRX) through any online brokerage.
Other companies in ContraFect’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Bone Biologics (NASDAQ:BBLG), Histogen (NASDAQ:HSTO), Midatech Pharma (NASDAQ:MTP) and OncoSec Medical (NASDAQ:ONCS).
The latest price target for ContraFect (NASDAQ: CFRX) was reported by Maxim Group on Thursday, July 14, 2022. The analyst firm set a price target for 0.00 expecting CFRX to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
The stock price for ContraFect (NASDAQ: CFRX) is $0.0696 last updated February 3, 2023 at 9:00 PM UTC.
There are no upcoming dividends for ContraFect.
ContraFect’s Q4 earnings are confirmed for Thursday, March 23, 2023.
There is no upcoming split for ContraFect.
ContraFect is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
ContraFect Stock (NASDAQ: CFRX) stock price, news, charts, stock research, profile.
Day Range0.068 - 0.072 | 52 Wk Range0.059 - 4.540 | Open / Close0.070 / 0.070 | Float / Outstanding43.638M / 43.683M |
Vol / Avg.8.881M / 9.799M | Mkt Cap3.040M | P/E- | 50d Avg. Price0.110 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float43.638M | EPS-1.520 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-23 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.230 | -0.430 | -0.2000 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of ContraFect (NASDAQ: CFRX) through any online brokerage.
Other companies in ContraFect’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Bone Biologics (NASDAQ:BBLG), Histogen (NASDAQ:HSTO), Midatech Pharma (NASDAQ:MTP) and OncoSec Medical (NASDAQ:ONCS).
The latest price target for ContraFect (NASDAQ: CFRX) was reported by Maxim Group on Thursday, July 14, 2022. The analyst firm set a price target for 0.00 expecting CFRX to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
The stock price for ContraFect (NASDAQ: CFRX) is $0.0696 last updated February 3, 2023 at 9:00 PM UTC.
There are no upcoming dividends for ContraFect.
ContraFect’s Q4 earnings are confirmed for Thursday, March 23, 2023.
There is no upcoming split for ContraFect.
ContraFect is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.